|
As scientists link oral bacteria to heart disease and cognitive decline, a push is under way to treat the mouth as a source of bodywide inflammation.
For example, immunologist John D. Lambris, PhD, the Dr. Ralph and Sallie Weaver Professor of Research Medicine in Pathology and Laboratory Medicine, and George Hajishengallis, DDS, PhD, of Penn Dental, led research that resulted in the development of an experimental drug applied into gum tissue, aimed at calming the immune response.
|